1. Exploration of a Novel Prognostic Risk Signature and Its Effect on the Immune Response in Nasopharyngeal Carcinoma
   Shuang Zhao et al, 2021, Frontiers in Oncology CrossRef
2. Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA Pathway
   Dongyang Gao et al, 2021, Journal of Oncology CrossRef
3. RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
   Sarah Bajan et al, 2020, Cells CrossRef
4. Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs
   Zhiguo Wang et al, 2022, Polypharmacology CrossRef
5. A Five-MicroRNA Signature Predicts the Prognosis in Nasopharyngeal Carcinoma
   Shixiong Wu et al, 2021, Frontiers in Oncology CrossRef
6. Cuproptosis related ceRNA axis AC008083.2/miR-142-3p promotes the malignant progression of nasopharyngeal carcinoma through STRN3
   Dandan Feng et al, 2024, PeerJ CrossRef
7. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
   Wanzhen Li et al, 2021, PeerJ CrossRef
8. Identification of a 3-miRNA Signature Associated With the Prediction of Prognosis in Nasopharyngeal Carcinoma
   Jinhui Zhou et al, 2022, Frontiers in Oncology CrossRef
9. Construction and Analysis of lncRNA-Mediated ceRNA Network in Nasopharyngeal Carcinoma Based on Weighted Correlation Network Analysis
   Zhenning Zou et al, 2020, BioMed Research International CrossRef